DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q2 EPS

Go back to DiaMedica Therapeutics Inc. (DMAC) Reports In-Line Q2 EPS
(NASDAQ: DMAC) Delayed: 6.90 +0.03 (0.44%)
Previous Close $6.87    52 Week High
Open $6.94    52 Week Low
Day High $7.13    P/E N/A 
Day Low $6.74    EPS
Volume 71,073